4//SEC Filing
Guse Kyle 4
Accession 0001437749-21-012675
CIK 0001488039other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 4:18 PM ET
Size
5.1 KB
Accession
0001437749-21-012675
Insider Transaction Report
Form 4
Guse Kyle
CFO & General Counsel
Transactions
- Award
Stock Option (right to buy)
2021-05-14+850,000→ 850,000 totalExercise: $2.90Exp: 2031-05-14→ Common Stock (850,000 underlying)
Footnotes (1)
- [F1]The options will vest on a quarterly basis over the next 24 months. Option grant was issued at 4:30 p.m. (ET) on May 14, 2021 with an exercise price of $2.90, representing the most recently reported closing stock price at the time of grant.
Documents
Issuer
ATOSSA THERAPEUTICS, INC.
CIK 0001488039
Entity typeother
Related Parties
1- filerCIK 0001566618
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 4:18 PM ET
- Size
- 5.1 KB